Aberrant phosphorylation and aggregation are key features of tau in the brains of AD patients, and high stoichiometric increased tau phosphorylation (hyperphosphorylation) is thought to result in tau dysfunction and pathological properties1,38. Here, MAPT is linked to Alzheimer disease.